Clinical Trial Update: Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing alendronate to prevent femoral head collapse in non-traumatic osteonecrosis; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-traumatic Osteonecrosis

Drugs mentioned

• FOSAMAX (ALENDRONATE SODIUM)
• alendronate (alendronate)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Non-Traumatic Osteonecrosis | Phase 4 | Status: UNKNOWN